ProQR Therapeutics N.V.
PRQR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $149 | $131 | $95 | $188 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $1 | $56 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $1 | $3 | $4 |
| Total Curr. Assets | $154 | $134 | $154 | $191 |
| Property Plant & Equip (Net) | $14 | $19 | $16 | $17 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $14 | $19 | $17 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $168 | $152 | $171 | $210 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $0 | $0 |
| Short-Term Debt | $6 | $2 | $4 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $23 | $0 | $0 |
| Other Curr. Liab. | $33 | $12 | $17 | $21 |
| Total Curr. Liab. | $39 | $38 | $21 | $28 |
| LT Debt | $11 | $20 | $18 | $54 |
| Deferred Rev, NC | $0 | $49 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $29 | $0 | $66 | $15 |
| Total NC Liab. | $40 | $69 | $84 | $69 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $15 | $15 | $16 |
| Total Liabilities | $79 | $107 | $105 | $96 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $3 | $3 |
| Retained Earnings | -$427 | -$443 | -$379 | -$318 |
| AOCI | $28 | $29 | $30 | $30 |
| Other Equity | $484 | $456 | $413 | $398 |
| Total Equity | $89 | $46 | $67 | $114 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | -$0 | -$1 |
| Total Liab. & Tot. Equity | $168 | $152 | $171 | $210 |
| Net Debt | -$132 | -$110 | -$73 | -$127 |